501–550 of 20,598 genesranked by Most Researched
| # | Gene | Name | Chr | Tags | PubMed Papers |
|---|---|---|---|---|---|
| 501 | TIMP2 | TIMP metallopeptidase inhibitor 2 | 17 | Highly StudiedExperimental GO Evidence | 522 |
| 502 | XRCC3 | X-ray repair cross complementing 3 | 14 | DNA RepairHomologous Recombination | 520 |
| 503 | HDAC6 | histone deacetylase 6 | X | Highly ConstrainedHub Gene | 519 |
| 504 | RASSF1 | Ras association domain family member 1 | 3 | Tumor SuppressorHighly Studied | 519 |
| 505 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 5 | Highly ConstrainedHub Gene | 518 |
| 506 | BCL2L11 | BCL2 like 11 | 2 | Highly StudiedExperimental GO Evidence | 517 |
| 507 | IL6R | interleukin 6 receptor | 1 | Hub GeneReceptor | 517 |
| 508 | BRD4 | bromodomain containing 4 | 19 | Highly ConstrainedHub Gene | 516 |
| 509 | TUBB | tubulin beta class I | 6 | Highly ConstrainedHub Gene | 516 |
| 510 | GATA3 | GATA binding protein 3 | 10 | Hub GeneTranscription Factor | 515 |
| 511 | IDH2 | isocitrate dehydrogenase (NADP(+)) 2 | 15 | Hub GeneFDA Approved Target | 515 |
| 512 | RXRA | retinoid X receptor alpha | 9 | Highly ConstrainedHub Gene | 515 |
| 513 | IDO1 | indoleamine 2,3-dioxygenase 1 | 8 | Hub GeneFDA Approved Target | 514 |
| 514 | LPA | lipoprotein(a) | 6 | ProteaseTransporter | 514 |
| 515 | BMP4 | bone morphogenetic protein 4 | 14 | Highly ConstrainedHub Gene | 513 |
| 516 | EIF4E | eukaryotic translation initiation factor 4E | 4 | Highly ConstrainedHub Gene | 513 |
| 517 | MMP7 | matrix metallopeptidase 7 | 11 | ProteaseFDA Approved Target | 513 |
| 518 | CYP1A2 | cytochrome P450 family 1 subfamily A member 2 | 15 | Hub GeneHighly Studied | 511 |
| 519 | MYCN | MYCN proto-oncogene, bHLH transcription factor | 2 | Highly ConstrainedOncogene | 511 |
| 520 | PINK1 | PTEN induced kinase 1 | 1 | Hub GeneKinase | 510 |
| 521 | SRSF1 | serine and arginine rich splicing factor 1 | 17 | Highly ConstrainedHub Gene | 510 |
| 522 | HDAC3 | histone deacetylase 3 | 5 | Hub GeneFDA Approved Target | 509 |
| 523 | NOTCH3 | notch receptor 3 | 19 | ReceptorClinical Trials | 508 |
| 524 | STING1 | stimulator of interferon response cGAMP interactor 1 | 5 | Ion ChannelTransporter | 508 |
| 525 | ANXA1 | annexin A1 | 9 | Highly StudiedTrending | 507 |
| 526 | EWSR1 | EWS RNA binding protein 1 | 22 | Highly ConstrainedHub Gene | 507 |
| 527 | IL15 | interleukin 15 | 4 | Hub GeneClinical Trials | 506 |
| 528 | S100B | S100 calcium binding protein B | 21 | Highly StudiedExperimental GO Evidence | 506 |
| 529 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | 20 | Highly ConstrainedHub Gene | 505 |
| 530 | BCR | BCR activator of RhoGEF and GTPase | 22 | KinaseOncogene | 502 |
| 531 | TNFSF13B | TNF superfamily member 13b | 13 | FDA Approved TargetHighly Studied | 502 |
| 532 | IGF2BP3 | insulin like growth factor 2 mRNA binding protein 3 | 7 | Highly ConstrainedTransporter | 501 |
| 533 | ITGA5 | integrin subunit alpha 5 | 12 | Hub GeneReceptor | 501 |
| 534 | CFL1 | cofilin 1 | 11 | Hub GeneHighly Studied | 499 |
| 535 | PTBP1 | polypyrimidine tract binding protein 1 | 19 | Highly ConstrainedHub Gene | 499 |
| 536 | VEGFC | vascular endothelial growth factor C | 4 | Clinical TrialsOMIM Disease Gene | 497 |
| 537 | ARID1A | AT-rich interaction domain 1A | 1 | Highly ConstrainedHub Gene | 494 |
| 538 | MC4R | melanocortin 4 receptor | 18 | ReceptorFDA Approved Target | 494 |
| 539 | PTX3 | pentraxin 3 | 3 | Highly StudiedTrending | 494 |
| 540 | DNMT3B | DNA methyltransferase 3 beta | 20 | Hub GeneOMIM Disease Gene | 492 |
| 541 | FCGR3A | Fc gamma receptor IIIa | 1 | Hub GeneReceptor | 492 |
| 542 | ERG | ETS transcription factor ERG | 21 | Highly ConstrainedOncogene | 491 |
| 543 | PRDX1 | peroxiredoxin 1 | 1 | Highly StudiedTrending | 491 |
| 544 | MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | 1 | Hub GeneOMIM Disease Gene | 489 |
| 545 | CAT | catalase | 11 | OMIM Disease GeneHighly Studied | 488 |
| 546 | PTPN1 | protein tyrosine phosphatase non-receptor type 1 | 20 | Highly ConstrainedHighly Studied | 488 |
| 547 | SOCS1 | suppressor of cytokine signaling 1 | 16 | Hub GeneOMIM Disease Gene | 486 |
| 548 | F7 | coagulation factor VII | 13 | ProteaseFDA Approved Target | 485 |
| 549 | B2M | beta-2-microglobulin | 15 | Hub GeneOMIM Disease Gene | 484 |
| 550 | H4C1 | H4 clustered histone 1 | 6 | Hub GeneHighly Studied | 484 |